ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase I first-in-human, dose-escalation and expansion study to evaluate the safety and tolerability of NUC-3373 in patients with locally advanced, unresectable or metastatic solid malignancies
Annals of Oncology
◽
10.1093/annonc/mdy279.429
◽
2018
◽
Vol 29
◽
pp. viii145
Author(s):
S. Blagden
◽
P. Spiliopoulou
◽
L. Spiers
◽
C. Gnanaranjan
◽
C. Qi
◽
...
Keyword(s):
Phase I
◽
Dose Escalation
◽
Locally Advanced
◽
Human Dose
◽
Solid Malignancies
Download Full-text
Related Documents
Cited By
References
Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose-escalation study
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/0360-3016(94)90141-4
◽
1994
◽
Vol 28
(1)
◽
pp. 55-65
◽
Cited By ~ 137
Author(s):
Steven A. Leibel
◽
Ruth Heimann
◽
Gerald J. Kutcher
◽
Michael J. Zelefsky
◽
Chandra M. Burman
◽
...
Keyword(s):
Radiation Therapy
◽
Phase I
◽
Dose Escalation
◽
Locally Advanced
◽
Three Dimensional
◽
Dose Escalation Study
◽
Conformal Radiation Therapy
◽
Advanced Carcinoma
◽
Preliminary Results
◽
Carcinoma Of The Prostate
Download Full-text
Abstract CT214: ATRiUM: A first-in-human dose escalation phase I trial of ceralasertib (AZD6738) and gemcitabine as combination therapy
10.1158/1538-7445.am2021-ct214
◽
2021
◽
Author(s):
Bruno Henrique de Paula
◽
Bristi Basu
◽
Adrian Mander
◽
Josephine Khan
◽
Purity Bundi
◽
...
Keyword(s):
Combination Therapy
◽
Phase I
◽
Dose Escalation
◽
Phase I Trial
◽
Human Dose
Download Full-text
Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies
Oncology
◽
10.1159/000440958
◽
2015
◽
Vol 90
(1)
◽
pp. 10-20
◽
Cited By ~ 2
Author(s):
Rastislav Bahleda
◽
Jackie Baker
◽
Christophe Massard
◽
Sirish M. Gadgeel
◽
Jane E. Rogers
◽
...
Keyword(s):
Phase I
◽
Pharmacokinetic Study
◽
Dose Escalation
◽
Solid Malignancies
Download Full-text
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies
Investigational New Drugs
◽
10.1007/s10637-010-9444-0
◽
2010
◽
Vol 29
(5)
◽
pp. 996-1003
◽
Cited By ~ 15
Author(s):
Benoit You
◽
Anthony Brade
◽
Joao M. Magalhaes
◽
Lillian L. Siu
◽
Amit Oza
◽
...
Keyword(s):
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Epidermal Growth Factor
◽
Phase I
◽
Dose Escalation
◽
Phase I Trial
◽
Growth Factor Receptor
◽
Solid Malignancies
◽
Epidermal Growth
Download Full-text
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: Results of a phase I study (LARA-CC-1)
Gynecologic Oncology
◽
10.1016/j.ygyno.2010.04.017
◽
2010
◽
Vol 118
(2)
◽
pp. 128-133
◽
Cited By ~ 10
Author(s):
Gabriella Macchia
◽
Gabriella Ferrandina
◽
Francesco Deodato
◽
Valeria Ruggieri
◽
Mariangela Massaccesi
◽
...
Keyword(s):
Phase I
◽
Dose Escalation
◽
Uterine Cervix
◽
Phase I Study
◽
Locally Advanced
◽
Preoperative Chemoradiation
◽
Large Field
◽
Advanced Carcinoma
◽
Concomitant Boost
◽
Boost Dose
Download Full-text
Carbon-ion Radiation Therapy for Locally Advanced Primary or Postoperative Recurrent Epithelial Carcinoma of Lacrimal Gland: A Phase I/II Dose-escalation Study
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2012.07.738
◽
2012
◽
Vol 84
(3)
◽
pp. S283
Author(s):
N. Mizoguchi
◽
H. Tsuji
◽
S. Toyama
◽
T. Kamada
◽
H. Tsujii
◽
...
Keyword(s):
Radiation Therapy
◽
Phase I
◽
Lacrimal Gland
◽
Dose Escalation
◽
Locally Advanced
◽
Dose Escalation Study
◽
Carbon Ion
Download Full-text
Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study
Radiotherapy and Oncology
◽
10.1016/j.radonc.2018.02.002
◽
2018
◽
Vol 127
(1)
◽
pp. 43-48
◽
Cited By ~ 1
Author(s):
K.P. Rooney
◽
A.B. Miah
◽
S.A. Bhide
◽
M.T. Guerrero-Urbano
◽
M.T. Sharabiani
◽
...
Keyword(s):
Thyroid Cancer
◽
Phase I
◽
Dose Escalation
◽
Locally Advanced
◽
Intensity Modulated Radiotherapy
◽
Cancer Outcomes
◽
Dose Escalation Study
◽
Intensity Modulated
◽
Advanced Thyroid Cancer
◽
Sequential Phase
Download Full-text
Abstract B98: AUY922, a novel HSP90 inhibitor: Final results of a phase I dose escalation study in Japanese patients with advanced solid malignancies.
10.1158/1535-7163.targ-11-b98
◽
2011
◽
Cited By ~ 1
Author(s):
Yusuke Onozawa
◽
Toshihiko Doi
◽
Kentaro Yamazaki
◽
Junichiro Watanabe
◽
Nozomu Fuse
◽
...
Keyword(s):
Phase I
◽
Dose Escalation
◽
Japanese Patients
◽
Hsp90 Inhibitor
◽
Dose Escalation Study
◽
Solid Malignancies
Download Full-text
Abstract CT206: PFK-158, first-in-man and first-in-class inhibitor of PFKFB3/ glycolysis: A phase I, dose escalation, multi-center study in patients with advanced solid malignancies
10.1158/1538-7445.am2015-ct206
◽
2015
◽
Cited By ~ 3
Author(s):
Rebecca Redman
◽
Paula Pohlmann
◽
Michael Kurman
◽
Gilles H. Tapolsky
◽
Jason Chesney
Keyword(s):
Phase I
◽
Dose Escalation
◽
Solid Malignancies
◽
Multi Center Study
◽
Center Study
Download Full-text
Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors
The Oncologist
◽
10.1634/theoncologist.2018-0740
◽
2018
◽
Vol 24
(4)
◽
pp. 455
◽
Cited By ~ 4
Author(s):
Johanna C. Bendell
◽
Manish R. Patel
◽
Kathleen N. Moore
◽
Cynthia C. Chua
◽
Hendrik‐Tobias Arkenau
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
◽
Human Dose
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close